RecruitingNot Applicable

Diagnostic and Prognostic Value of Reticulated Platelet Fraction in Ventilator-Associated Pneumonia (REPLAY-VAP)

Turkey (Türkiye)42 participantsStarted 2025-07-01

Plain-language summary

Ventilator-associated pneumonia (VAP) is a serious infection that occurs in patients who have been on mechanical ventilation for more than 48 hours in the intensive care unit (ICU). Early and accurate diagnosis is critical to reduce complications and improve outcomes. This prospective observational study aims to evaluate the diagnostic and prognostic value of reticulated platelet fraction (RP%) in patients diagnosed with VAP. Blood samples will be taken as part of routine care, and RP% levels will be analyzed using a standard hematology analyzer. The study will investigate whether RP% can help identify VAP earlier and predict outcomes such as mortality and response to antibiotics.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older * Receiving mechanical ventilation for more than 48 hours * Diagnosed with ventilator-associated pneumonia (VAP) according to clinical, radiologic, and laboratory criteria Exclusion Criteria: * Diagnosis of pneumonia upon ICU admission * Pneumonia as the primary reason for initiation of mechanical ventilation * Mechanical ventilation duration less than 48 hours * Pregnant or breastfeeding patients * Presence of chronic inflammatory conditions, hematologic disorders, malignancy, autoimmune disease, or immunosuppressive/chemotherapy/radiotherapy treatment within the past 4 weeks

What they're measuring

Diagnostic accuracy of reticulated platelet fraction (RP%) in diagnosing ventilator-associated pneumonia (VAP)

Timeframe: Within 48 hours of VAP diagnosis

Trial details

NCT IDNCT07013032

SponsorKonya City Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-02-01